Clinical Trial Update: Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the effects of recombinant human growth hormone in elderly patients with acute brain injury, including moderate to severe traum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Traumatic Brain Injury

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury | Phase 4 | Status: NOT_YET_RECRUITING